1. Mycek MJ, Illustrated Reviews Pharmacology, second edition, Lippincott Williams&Wilkins, Pennsylvania, USA, 2000, pp. 179-187;
2. Katzung BG. Basic and Clinical Pharmacology, tenth edition, McGraw-Hill, Singapore, 2007, pp. 159-177;
3. Ibrahim MM, Hegazy MA, Abd El-Ghani MA. Application of a RP-HPLC method for comparative study on the degradation behavior of two angiotensin ii receptor antagonists, valsartan and losartan potassium. International Journal of Pharmaceutical, Chemical & Biological Sciences. (2015);5(2):417-26;
4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline: Stability Testing of New Drug Substances and Products Q1A (R2), Step 5, ICH Geneva, Aug. 2003.;
5. Jain D, Basniwal PK. Forced degradation and impurity profiling: recent trends in analytical perspectives. Journal of pharmaceutical and biomedical analysis. (2013);86: 11-35.;